Skip to content

Clinical trials

Phase 2/3 trials in Jordan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Jordan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20183
20191
20202
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC2
Jordan University of Science and Technology2
King Abdullah University Hospital1
King Hussein Cancer Center1
Novartis Pharmaceuticals1
Resverlogix Corp1
University of Jordan1
Urovant Sciences GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative2
Colorectal Neoplasms1
Crohn Disease1
Gingival Recession1
Meningocele1
Meningomyelocele1
Myelitis, Transverse1
Post-Acute COVID-19 Syndrome1
Postoperative Pain1
Spinal Cord Injuries1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.